Cisplatin-resistant cancer cells sensitive to experimental anticancer drugs called PARP inhibitors
Wednesday, April 3, 2013 - 08:00
in Health & Medicine
Poly (ADP-ribose) polymerase inhibitors may be a novel treatment strategy for patients with cancer that has become resistant to the commonly used chemotherapy drug cisplatin, according to data from a preclinical study.